OtherPublishAheadOfPrint
Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
Walter Jentzen, Lutz Freudenberg, Ernst G. Eising, Wilfried Sonnenschein, Jochen Knust and Andreas Bockisch
Journal of Nuclear Medicine May 2008, DOI: https://doi.org/10.2967/jnumed.107.047159
Walter Jentzen
Lutz Freudenberg
Ernst G. Eising
Wilfried Sonnenschein
Jochen Knust
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
Walter Jentzen, Lutz Freudenberg, Ernst G. Eising, Wilfried Sonnenschein, Jochen Knust, Andreas Bockisch
Journal of Nuclear Medicine May 2008, DOI: 10.2967/jnumed.107.047159
Jump to section
Related Articles
Cited By...
- Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
- Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
- Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
- Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics
- Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
- Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
- Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
- Iodine Symporter Targeting with 124I/131I Theranostics
- Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry-Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
- 124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer
- High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases
- Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
- Quantitative Comparison of 124I PET/CT and 131I SPECT/CT Detectability
- Assessment of Simplified Blood Dose Protocols for the Estimation of the Maximum Tolerable Activity in Thyroid Cancer Patients Undergoing Radioiodine Therapy Using 124I
- Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging
- Dosimetry and thyroid cancer: the individual dosage of radioiodine
- Identification of a Shine-Through Artifact in the Trachea with 124I PET/CT